MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. (Q48595565)

13 February 2018

title

MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. (English)

1 reference

13 February 2018

1 reference

Wanghao Chen

1

1 reference

13 February 2018

Yong Yang

2

1 reference

13 February 2018

Bo Chen

3

1 reference

13 February 2018

Peisong Lu

4

1 reference

13 February 2018

Liping Zhan

5

1 reference

13 February 2018

Qiang Yu

6

1 reference

13 February 2018

Kan Cao

7

1 reference

13 February 2018

Qiaoyu Li

8

1 reference

13 February 2018

publication date

20 August 2014

1 reference

13 February 2018

Journal of Neuro-Oncology

published in

1 reference

13 February 2018

volume

120

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

43-53

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-014-1535-x

exact match

0 references

cites work

Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Maintenance of muscle stem-cell quiescence by microRNA-489

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Antagonistic interplay between necdin and Bmi1 controls proliferation of neural precursor cells in the embryonic mouse neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1535-X

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25139024

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25139024

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25139024

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-014-1535-X

1 reference

13 February 2018

PubMed ID

25139024

1 reference

13 February 2018